Clinical Trial Update: L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating L-Threonic Acid Magnesium Salt (L-TAMS) for ADHD has completed, with results posted in May 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• L-Threonic Acid Magnesium Salt (L-TAMS)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit/Hyperactivity Disorder, ADHD | Phase 2 | Status: COMPLETED | Results posted: 2018-05-14